Monthly injectable naltrexone for pathological gambling

American Journal of Psychiatry

Volumn 170, Issue 6, 2013, Pages 682-683

  Yoon, Gihyun ^a   Kim, Suck Won ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CITALOPRAM; CLONAZEPAM; NALTREXONE; NONSTEROID ANTIINFLAMMATORY AGENT; PRAMIPEXOLE;

ADULT; ALCOHOL ABSTINENCE; ALCOHOLISM; CASE REPORT; DEPRESSION; DISEASE DURATION; DRUG DOSE INCREASE; DRUG SUBSTITUTION; DRUG WITHDRAWAL; FOLLOW UP; HUMAN; INJECTION; LETTER; LIVER TOXICITY; MALE; MUSCLE SPASM; OPIATE ADDICTION; PATHOLOGICAL GAMBLING; PATIENT COMPLIANCE; PRIORITY JOURNAL; REMISSION; RESTLESS LEGS SYNDROME; TREATMENT DURATION; TREATMENT OUTCOME; ARTICLE; DRUG ADMINISTRATION; GAMBLING; INTRAMUSCULAR DRUG ADMINISTRATION; MEDICATION COMPLIANCE; MIDDLE AGED;

DRUG ADMINISTRATION SCHEDULE; GAMBLING; HUMANS; INJECTIONS, INTRAMUSCULAR; MALE; MEDICATION ADHERENCE; MIDDLE AGED; NALTREXONE;

EID: 84882246313     PISSN: 0002953X     EISSN: 15357228     Source Type: Journal    
DOI: 10.1176/appi.ajp.2013.12111469     Document Type: Letter

References (4)

1. Hodgins DC, Stea JN, Grant JE: Gambling disorders. Lancet 2011; 378: 1874-1884
2. Kranzler HR, Stephenson JJ, Montejano L, Wang S, Gastfriend DR: Persistence with oral naltrexone for alcohol treatment: implications for health-care utilization. Addiction 2008; 103: 1801-1808
3. Kim SW, Grant JE, Adson DE, Shin YC: Double-blind naltrexone and placebo comparison study in the treatment of pathological gambling. Biol Psychiatry 2001; 49: 914-921
4. Lucey MR, Silverman BL, Illeperuma A, O'Brien CP: Hepatic safety of once-monthly injectable extended-release naltrexone administered to actively drinking alcoholics. Alcohol Clin Exp Res 2008; 32: 498-504